Beutel, Goodman & CO Ltd. Merck & Co., Inc. Transaction History
Beutel, Goodman & CO Ltd.
- $20.3 Billion
- Q3 2024
A detailed history of Beutel, Goodman & CO Ltd. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Beutel, Goodman & CO Ltd. holds 3,446,817 shares of MRK stock, worth $338 Million. This represents 1.93% of its overall portfolio holdings.
Number of Shares
3,446,817
Previous 2,463,939
39.89%
Holding current value
$338 Million
Previous $305 Million
28.32%
% of portfolio
1.93%
Previous 1.62%
Shares
29 transactions
Others Institutions Holding MRK
# of Institutions
3,827Shares Held
1.87BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.5 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.3 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.7 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.43 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.8 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $248B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...